CARDIOVASCULAR RISK ASSOCIATED WITH COX-2 INHIBITOR DIFFERS BY DOSE

Research presented today at the American College of Cardiology's 57th Annual Scientific Session s...  More »

Research presented today at the American College of Cardiology's 57th Annual Scientific Session suggests that physicians should prescribe the lowest doses of Celecoxib possible, especially in higher risk patients.  « Less